PHARMACOVIGILANCE AND RISK MANAGEMENT CONSIDERATION FOR RARE DISEASE GENE THERAPIES

Estimation of the number of rare diseases and thereby estimates of the global population affected is never going to be an exact science, not only due to different interpretations of the terminology but also due to differences in describing and recording the conditions and misdiagnosis of conditions as other ailments.
Read more...

;